FDA 将 Mallinckrodt Acthar Gel 颗粒污染召回列为 II 类(D-0803-2026)
FDA drug enforcement D-0803-2026: Mallinckrodt Hospital Products Inc. — Presence of particulate matter: glass and stopper piece
Mallinckrodt Hospital Products Inc. 自愿召回 Acthar Gel 注射液,原因是产品中存在玻璃和胶塞颗粒,FDA 将其归类为 II 类召回(编号 D-0803-2026)。
记录列出召回产品的批号、分销范围与玻璃及胶塞颗粒的缺陷原因,可供质量团队核对同批号产品的流向。
FDA drug recall enforcement report — D-0803-2026
Report issued: 2026-09-02. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "440 Us Highway 22 Ste 302",
"address_2": "N/A",
"center_classification_date": "20260826",
"city": "Bridgewater",
"classification": "Class II",
"code_info": "Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027",
"country": "United States",
"distribution_pattern": "USA Nationwide",
"event_id": "99570",
"initial_firm_notification": "Letter",
"openfda": {},
"postal_code": "08807-2477",
"product_description": "Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2",
"product_quantity": "12367 vials",
"product_type": "Drugs",
"reason_for_recall": "Presence of particulate matter: glass and stopper piece",
"recall_initiation_date": "20260806",
"recall_number": "D-0803-2026",
"recalling_firm": "Mallinckrodt Hospital Products Inc.",
"report_date": "20260902",
"state": "NJ",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov